Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MethylGene Inc MYLGF

Healthcare Biotechnology


GREY:MYLGF - Post by User

MethylGene Inc > FACTS....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Everswanon Feb 09, 2010 10:47pm
201 Views
Post# 16769548

RE: FACTS....

RE: FACTS....
The company came out and said to all shareholders.

By Sept 2010, we will go broke.
Now I guess that a convincing reason to invest all your money here....

FACTS speak for themselves.

MYG is a high risk very early stage company with no hope of striking an anti-dilutive partnership deal.
Worst, MYG cap is so small that they cannot refinance.

Question for Shareholders is the following.

Is it better to fold the company and take out whatever cash there is or wait for what exactly???


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities